In the BioHarmony Drug Report Database
[COVID-19 Potential Therapeutics]
Includes access to the collection of COVID-19 Potential Therapeutic Drugs, including all current and future drug reports in the set (within a given subscription period).
The [COVID-19 Potential Therapeutic Drugs] data set contains over 70 drug reports.
One example of an included drug report data is shown below for Veklury.
Read the BioHarmony COVID-19 Case Study conducted using a subset of the 10 most frequently evaluated drugs in clinical trials against COVID-19 as of April 2021.
The case study includes a FREE 30-day trial evaluation of the study data set, [Case Study: Key COVID-19 Drugs].
Trade Name
|
Veklury |
|---|---|
Common Name
|
remdesivir |
ChEMBL ID
|
CHEMBL4065616 |
Indication
|
coronavirus, coronavirus infections, virus diseases |
Drug Class
|
Antivirals: adenosine analogs acting as RNA polymerase inhibitors |
Image (chem structure or protein)